Northern America: Antisera Market 2024

Antisera Market Size in Northern America

In 2022, the North American antisera market decreased by X% to $X, falling for the second consecutive year after three years of growth. Over the period under review, consumption saw a prominent increase. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Antisera Production in Northern America

In value terms, antisera production stood at $X in 2022 estimated in export price. Over the period under review, production saw buoyant growth. The pace of growth was the most pronounced in 2013 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Antisera Exports

Exports in Northern America

In 2022, shipments abroad of antisera and other blood fractions increased by X% to X tons, rising for the second year in a row after two years of decline. Total exports indicated a resilient expansion from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2021 when exports increased by X% against the previous year. Over the period under review, the exports attained the maximum in 2022 and are likely to see gradual growth in years to come.

In value terms, antisera exports surged to $X in 2022. Overall, exports enjoyed a prominent increase. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. Over the period under review, the exports attained the peak figure in 2022 and are likely to see steady growth in years to come.

Exports by Country

In 2022, the United States (X tons) represented the key exporter of antisera and other blood fractions, achieving X% of total exports. It was distantly followed by Canada (X tons), constituting a X% share of total exports.

Exports from the United States increased at an average annual rate of X% from 2012 to 2022. At the same time, Canada (X%) displayed positive paces of growth. Moreover, Canada emerged as the fastest-growing exporter exported in Northern America, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of Canada increased by X percentage points.

In value terms, the United States ($X) remains the largest antisera supplier in Northern America, comprising X% of total exports. The second position in the ranking was held by Canada ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in the United States stood at X%.

Export Prices by Country

In 2022, the export price in Northern America amounted to $X per ton, with an increase of X% against the previous year. Export price indicated a strong increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 when the export price increased by X%. Over the period under review, the export prices hit record highs in 2022 and is likely to see steady growth in the near future.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United States ($X per ton), while Canada amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (X%).

Antisera Imports

Imports in Northern America

In 2022, antisera imports in Northern America soared to X tons, rising by X% on 2021 figures. Overall, imports posted a prominent increase. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. The volume of import peaked in 2022 and is expected to retain growth in the immediate term.

In value terms, antisera imports rose significantly to $X in 2022. Over the period under review, imports saw a significant increase. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. The level of import peaked in 2022 and is likely to continue growth in the immediate term.

Imports by Country

The countries with the highest levels of antisera imports in 2022 were Canada (X tons) and the United States (X tons), together accounting for X% of total import.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by the United States (with a CAGR of X%).

In value terms, the United States ($X) constitutes the largest market for imported antisera and other blood fractions in Northern America, comprising X% of total imports. The second position in the ranking was held by Canada ($X), with an X% share of total imports.

From 2012 to 2022, the average annual growth rate of value in the United States stood at X%.

Import Prices by Country

The import price in Northern America stood at $X per ton in 2022, declining by X% against the previous year. In general, the import price, however, posted a remarkable increase. The most prominent rate of growth was recorded in 2016 an increase of X% against the previous year. Over the period under review, import prices hit record highs at $X,073 per ton in 2019; however, from 2020 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the United States ($X,898 per ton), while Canada amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Canada (X%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :